{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:38Z","timestamp":1790763038053,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Lipoic acid synthetase (LIAS) has been demonstrated to play a crucial role in the progression of cancer. Exploring the underlying mechanisms and biological functions of LIAS could have potential therapeutic guidance for cancer treatment. Our study has explored the expression levels and prognostic values of LIAS in pan-cancer through several bioinformatics platforms, including TIMER2.0, Gene Expression Profiling Interactive Analysis, version 2 (GEPIA2.0), and Human Protein Atlas (HPA). We found that a high LIAS expression was related to the good prognosis in patients with kidney renal clear cell carcinoma (KIRC), rectum adenocarcinoma (READ), breast cancer, and ovarian cancer. Inversely, a high LIAS expression showed unfavorable prognosis in lung cancer patients. In addition, the genetic alteration, methylation levels, and immune analysis of LIAS in pan-cancer have been evaluated. To elucidate the underlying molecular mechanism of LIAS, we conduct the single-cell sequencing to implicate that LIAS expression was related to hypoxia, angiogenesis, and DNA repair. Thus, these comprehensive pan-cancer analyses have conveyed that LIAS could be potentially significant in the progression of various cancers. Moreover, the LIAS expression could predict the efficacy of immunotherapy in cancer patients.<\/jats:p>","DOI":"10.3389\/fonc.2022.952129","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T06:07:45Z","timestamp":1659420465000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhua","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203556","article-title":"Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression","volume":"13","author":"Fonseca","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203523","article-title":"Differential expression of long non-coding RNAs as diagnostic markers for lung cancer and other malignant tumors","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0308161","article-title":"Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury","volume":"85","author":"Yi","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2017.07.001","article-title":"Biallelic mutations in LIPT2 cause a mitochondrial lipoylation defect associated with severe neonatal encephalopathy","volume":"101","author":"Habarou","year":"2017","journal-title":"Am J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.11.011","article-title":"Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation","volume":"89","author":"Mayr","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1607","article-title":"A roadmap to generate renewable protein binders to the human proteome","volume":"8","author":"Colwill","year":"2011","journal-title":"Nat Methods"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","article-title":"The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions","volume":"30","author":"Oughtred","year":"2021","journal-title":"Protein Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2196\/27633","article-title":"Web-based survival analysis tool tailored for medical research (KMplot): Development and implementation","volume":"23","author":"Lanczky","year":"2021","journal-title":"J Med Internet Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1109\/TVCG.2019.2934307","article-title":"GPGPU linear complexity t-SNE optimization","volume":"26","author":"Pezzotti","year":"2020","journal-title":"IEEE Trans Vis Comput Graph"},{"key":"B17","doi-asserted-by":"publisher","first-page":"17346","DOI":"10.1038\/s41598-021-96844-0","article-title":"Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer","volume":"11","author":"Fain","year":"2021","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16782","DOI":"10.1038\/s41598-021-96242-6","article-title":"A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer","volume":"11","author":"Wei","year":"2021","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e.26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11625","article-title":"Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer","volume":"108","author":"Ito","year":"2004","journal-title":"Int J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.729018","article-title":"Evidence of antitumor and antimetastatic potential of induced pluripotent stem cell-based vaccines in cancer immunotherapy","volume":"8","author":"Kishi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.762247","article-title":"Rheumatic manifestations and diseases from immune checkpoint inhibitors in cancer immunotherapy","volume":"8","author":"Shen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1038\/s41598-021-81796-2","article-title":"Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis","volume":"11","author":"Irvine","year":"2021","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16779","DOI":"10.1038\/s41598-021-96344-1","article-title":"Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis","volume":"11","author":"Min","year":"2021","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203479","article-title":"Blood transfusion practices affect CD4(+) CD25(+) FOXP3(+) regulatory T cells\/T helper-17 cells and the clinical outcome of geriatric patients with hip fracture","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.785153","article-title":"Current progress and future perspectives of immune checkpoint in cancer and infectious diseases","volume":"12","author":"Cai","year":"2021","journal-title":"Front Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.952129\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T06:07:49Z","timestamp":1659420469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.952129\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":34,"alternative-id":["10.3389\/fonc.2022.952129"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.952129","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"article-number":"952129"}}